Article metrics

Download PDFPDF

Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication

 

Online download statistics by month:

Online download statistics by month: June 2020 to January 2024

AbstractFullPdf
Jun 202010310338
Jul 2020748038
Aug 2020434028
Sep 2020444451
Oct 2020282926
Nov 2020414046
Dec 202037379
Jan 2021424233
Feb 2021363622
Mar 2021414117
Apr 2021414136
May 2021545434
Jun 2021424232
Jul 2021333321
Aug 2021333321
Sep 2021454516
Oct 2021313132
Nov 2021424229
Dec 2021434510
Jan 2022293014
Feb 2022272921
Mar 2022414223
Apr 2022303116
May 2022333314
Jun 2022313213
Jul 202224248
Aug 202234349
Sep 2022373733
Oct 2022343515
Nov 2022343625
Dec 202223237
Jan 202315157
Feb 202346465
Mar 2023171811
Apr 2023121219
May 202310107
Jun 202312129
Jul 2023999
Aug 202315158
Sep 202316166
Oct 202313133
Nov 202316165
Dec 2023222213
Jan 202418199
Total14511467848